Cargando…

A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is one of the most common types of cardiac amyloidosis. Amyloid cardiomyopathy more commonly affects men, elderly, and 3% to 4% of the African-American population. ATTR-CM suspicion and diagnosis is challenging; however, awareness of the dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Juarez, Michel, Del Rio-Pertuz, Gaspar, Parmar, Kanak, Bois, Melanie C., Shurmur, Scott, Argueta-Sosa, Erwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743975/
https://www.ncbi.nlm.nih.gov/pubmed/34983267
http://dx.doi.org/10.1177/21501319211062682
_version_ 1784630025308340224
author Juarez, Michel
Del Rio-Pertuz, Gaspar
Parmar, Kanak
Bois, Melanie C.
Shurmur, Scott
Argueta-Sosa, Erwin
author_facet Juarez, Michel
Del Rio-Pertuz, Gaspar
Parmar, Kanak
Bois, Melanie C.
Shurmur, Scott
Argueta-Sosa, Erwin
author_sort Juarez, Michel
collection PubMed
description Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is one of the most common types of cardiac amyloidosis. Amyloid cardiomyopathy more commonly affects men, elderly, and 3% to 4% of the African-American population. ATTR-CM suspicion and diagnosis is challenging; however, awareness of the disease is increasing, and best practices to identify it are being proposed. The approach to suspected cases of ATTR-CM relies on the presence of heart failure, red flag signs and symptoms, and age >65 or >70 for men and women respectively. Little is known about cases when it presents in early ages. Case: We report a 62-year-old African American male with past medical history of hyperlipidemia, prostate cancer, hypertension, bilateral carpal tunnel surgery that had debuted with a cardiac arrhythmia at age 55 and was diagnosed with heart failure several years later. Restrictive cardiomyopathy was suspected, and genetic screening was sent for ATTRm which confirmed a pathogenic trasnthyretin gene mutation. Endomyocardial biopsy was performed which confirmed cardiac amyloid deposition. Discussion: ATTR-CM is a rare disease with an increasing prevalence. Cases with out of proportion signs and symptoms of heart failure with preserved ejection fractions should raise the suspicion of ATTR-CM despite age.
format Online
Article
Text
id pubmed-8743975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87439752022-01-11 A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report Juarez, Michel Del Rio-Pertuz, Gaspar Parmar, Kanak Bois, Melanie C. Shurmur, Scott Argueta-Sosa, Erwin J Prim Care Community Health Case Studies Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is one of the most common types of cardiac amyloidosis. Amyloid cardiomyopathy more commonly affects men, elderly, and 3% to 4% of the African-American population. ATTR-CM suspicion and diagnosis is challenging; however, awareness of the disease is increasing, and best practices to identify it are being proposed. The approach to suspected cases of ATTR-CM relies on the presence of heart failure, red flag signs and symptoms, and age >65 or >70 for men and women respectively. Little is known about cases when it presents in early ages. Case: We report a 62-year-old African American male with past medical history of hyperlipidemia, prostate cancer, hypertension, bilateral carpal tunnel surgery that had debuted with a cardiac arrhythmia at age 55 and was diagnosed with heart failure several years later. Restrictive cardiomyopathy was suspected, and genetic screening was sent for ATTRm which confirmed a pathogenic trasnthyretin gene mutation. Endomyocardial biopsy was performed which confirmed cardiac amyloid deposition. Discussion: ATTR-CM is a rare disease with an increasing prevalence. Cases with out of proportion signs and symptoms of heart failure with preserved ejection fractions should raise the suspicion of ATTR-CM despite age. SAGE Publications 2022-01-04 /pmc/articles/PMC8743975/ /pubmed/34983267 http://dx.doi.org/10.1177/21501319211062682 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Studies
Juarez, Michel
Del Rio-Pertuz, Gaspar
Parmar, Kanak
Bois, Melanie C.
Shurmur, Scott
Argueta-Sosa, Erwin
A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
title A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
title_full A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
title_fullStr A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
title_full_unstemmed A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
title_short A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report
title_sort case of early hereditary transthyretin amyloid cardiomyopathy recognition with genetic screening: a case report
topic Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743975/
https://www.ncbi.nlm.nih.gov/pubmed/34983267
http://dx.doi.org/10.1177/21501319211062682
work_keys_str_mv AT juarezmichel acaseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT delriopertuzgaspar acaseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT parmarkanak acaseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT boismelaniec acaseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT shurmurscott acaseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT arguetasosaerwin acaseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT juarezmichel caseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT delriopertuzgaspar caseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT parmarkanak caseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT boismelaniec caseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT shurmurscott caseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport
AT arguetasosaerwin caseofearlyhereditarytransthyretinamyloidcardiomyopathyrecognitionwithgeneticscreeningacasereport